HOME >> BIOLOGY >> NEWS
The next generation of scientists recognized at Johns Hopkins

The best of the best. The cream of the crop. Clichs may accurately describe the winners of this year's Young Investigators' Day awards at The Johns Hopkins University School of Medicine, but their work is anything but run of the mill.

Now in its 25th year, Young Investigators' Day recognizes the substantial contributions of all graduate school and medical students, postdoctoral fellows and medical residents and fellows throughout the school of medicine and hospital by rewarding the advances of some of Hopkins' most talented researchers in training.

This year's winning projects have brought a new anti-cancer drug to clinical trial, shown a common diagnostic observation not to be diagnostic at all and turned more than one scientific field on its head. The award recipients will present their study results and accept their awards April 11, beginning at 4 p.m. in Mountcastle Auditorium in the medical school's Preclinical Teaching Building.

"Young investigators are the heart and soul of the research enterprise," says Paul Talalay, M.D., a driving force in the creation of Young Investigators' Day back in 1978 and a continuing supporter. "Each year we take part in an extraordinary intellectual feast, really, in which our young investigators tell the larger Hopkins community about their discoveries. So many wonderful new ideas are presented, and a sense of happy excitement surrounds it."

The results of more than a few of the recognized projects have been or are about to be published in leading journals such as Cell, Science, Nature, The Lancet and The New England Journal of Medicine. But while publication in such journals validates the efforts of a budding scientist or research physician, recognition within Hopkins -- not to mention the award checks -- can be an important boost for young investigators.

"Having my work accepted for publication is a great feeling, but receiving recognition from people I know and have a great deal
'"/>

Contact: Joanna Downer
jdowner1@jhmi.edu
410-614-5105
Johns Hopkins Medical Institutions
9-Apr-2002


Page: 1 2 3

Related biology news :

1. Phase II trials of second-generation antisense cancer drug planned following successful early study
2. Disruption of protein-folding causes neurodegeneration, mental retardation
3. Double-segment periodicity underlies odd segment generation in centipedes
4. Gene defects found in age-related macular degeneration
5. UNC scientists discover molecular pathway leading to nerve growth and regeneration
6. Two billion vulnerable to floods by 2050; number expected to double or more in two generations
7. Continents played key role in collapse and regeneration of Earths early greenhouse, geologists say
8. Land Regeneration Network celebrates first year success
9. Regeneration of injured muscle from adult stem cells
10. First time in the U.S.: Saint Louis University tests third-generation vaccine against smallpox
11. Treatment stimulates growth and regeneration of injured adult skeletal muscle

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/1/2019)... ... July 31, 2019 , ... Molecular Devices, LLC, a leader ... generation of its FLIPR® Penta High-Throughput Cellular Screening System. , The new FLIPR ... of G-protein-coupled receptors (GPCRs) and ion channels, offering a new high-speed camera option ...
(Date:7/26/2019)... ... July 25, 2019 , ... Lemnis Technologies, the technology ... to include a new generation eye tracker with hassle-free calibration. The headsets will ... (July 30 - August 1). SIGGRAPH attendees will be able to try Verifocal™ ...
(Date:7/23/2019)... (PRWEB) , ... July 23, 2019 , ... ... of NanoSTRIP, a 100% bioactive glass synthetic biologic strip indicated for spine and ... (HA) similar to human bone. Bioactive glass has been clinically-proven in orthopedics for ...
Breaking Biology News(10 mins):
(Date:6/18/2019)... (PRWEB) , ... June 18, 2019 , ... Personalized ... Investigational New Drug (IND) application to the FDA for use of a person’s own ... as a treatment of osteoarthritis in the knee. This IND is the first ...
(Date:6/11/2019)... ... June 10, 2019 , ... Advancements with Ted ... episode, scheduled to broadcast 4Q/2019. Check your local listings for more information. , ... about how its technology facilitates laboratories to improve efficiency and quality of research ...
(Date:6/11/2019)... ... 11, 2019 , ... Veterinary Regenerative Medicine company, VetStem ... announced that their GMP facility for cell production is now approved by the ... is an important milestone for VetStem as it expands into contract cell manufacturing ...
(Date:5/31/2019)... ... 2019 , ... For many years, the primary forms of cancer treatment have ... Advances in immuno-oncology have led to the advent of Chimeric Antigen Receptor T (CAR ... receptors known as “CARs”. The CAR enables the final product to produce chemicals in ...
Breaking Biology Technology:
Cached News: